Protagonist Therapeutics, Inc. Profile Avatar - Palmy Investing

Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injec…

Biotechnology
US, Newark [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Protagonist Therapeutics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of PTGX's Analysis
CIK: 1377121 CUSIP: 74366E102 ISIN: US74366E1029 LEI: - UEI: -
Secondary Listings
PTGX has no secondary listings inside our databases.